Correlates of Health-related Quality of Life in African Americans Diagnosed with Cancer: a Review of Survivorship Studies and the Detroit Research on Cancer Survivors Cohort

Overview

Journal Cancer Metastasis Rev

Specialty Oncology

Date 2024 Jul 20

PMID 39033236

Authors

Matthew R Trendowski

Julie J Ruterbusch

Tara E Baird

Angela S Wenzlaff

Stephanie S Pandolfi

Theresa A Hastert

Ann G Schwartz

Jennifer L Beebe-Dimmer

Affiliations

Soon will be listed here.

Abstract

Advances in cancer screening and treatment have improved survival after a diagnosis of cancer. As the number of cancer survivors as well as their overall life-expectancy increases, investigations of health-related quality of life (HRQOL) are critical in understanding the factors that promote the optimal experience over the course of survivorship. However, there is a dearth of information on determinants of HRQOL for African American cancer survivors as the vast majority of cohorts have been conducted predominantly among non-Hispanic Whites. In this review, we provide a review of the literature related to HRQOL in cancer survivors including those in African Americans. We then present a summary of published work from the Detroit Research on Cancer Survivors (ROCS) cohort, a population-based cohort of more than 5000 African American cancer survivors. Overall, Detroit ROCS has markedly advanced our understanding of the unique factors contributing to poorer HRQOL among African Americans with cancer. This work and future studies will help inform potential interventions to improve the long-term health of this patient population.

References

Miller K, Nogueira L, Mariotto A, Rowland J, Yabroff K, Alfano C . Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019; 69(5):363-385. DOI: 10.3322/caac.21565. View

Han X, Robinson L, Jensen R, Smith T, Yabroff K . Factors Associated With Health-Related Quality of Life Among Cancer Survivors in the United States. JNCI Cancer Spectr. 2021; 5(1). PMC: 7883550. DOI: 10.1093/jncics/pkaa123. View

Du X, Lin C, Johnson N, Altekruse S . Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979-2003. Cancer. 2011; 117(14):3242-51. PMC: 3090714. DOI: 10.1002/cncr.25854. View

Matthews A, Tejeda S, Johnson T, Berbaum M, Manfredi C . Correlates of quality of life among African American and white cancer survivors. Cancer Nurs. 2012; 35(5):355-64. PMC: 3619385. DOI: 10.1097/NCC.0b013e31824131d9. View

Leach C, Weaver K, Aziz N, Alfano C, Bellizzi K, Kent E . The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv. 2014; 9(2):239-51. DOI: 10.1007/s11764-014-0403-1. View

Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B . Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncol. 2017; 56(2):190-197. DOI: 10.1080/0284186X.2016.1266089. View

Maurer T, Thone K, Obi N, Jung A, Behrens S, Becher H . Health-Related Quality of Life in a Cohort of Breast Cancer Survivors over More Than 10 Years Post-Diagnosis and in Comparison to a Control Cohort. Cancers (Basel). 2021; 13(8). PMC: 8069882. DOI: 10.3390/cancers13081854. View

van Leeuwen M, Husson O, Alberti P, Arraras J, Chinot O, Costantini A . Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire. Health Qual Life Outcomes. 2018; 16(1):114. PMC: 5987570. DOI: 10.1186/s12955-018-0920-0. View

Firkins J, Hansen L, Driessnack M, Dieckmann N . Quality of life in "chronic" cancer survivors: a meta-analysis. J Cancer Surviv. 2020; 14(4):504-517. DOI: 10.1007/s11764-020-00869-9. View

10.

Smith A, Reeve B, Bellizzi K, Harlan L, Klabunde C, Amsellem M . Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev. 2008; 29(4):41-56. PMC: 3142673. View

11.

Siembida E, Smith A, Potosky A, Graves K, Jensen R . Examination of individual and multiple comorbid conditions and health-related quality of life in older cancer survivors. Qual Life Res. 2021; 30(4):1119-1129. PMC: 7808400. DOI: 10.1007/s11136-020-02713-0. View

12.

Fu M, Axelrod D, Guth A, Cleland C, Ryan C, Weaver K . Comorbidities and Quality of Life among Breast Cancer Survivors: A Prospective Study. J Pers Med. 2015; 5(3):229-42. PMC: 4600145. DOI: 10.3390/jpm5030229. View

13.

Arneja J, Brooks J . The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada. PLoS One. 2021; 16(8):e0256536. PMC: 8389459. DOI: 10.1371/journal.pone.0256536. View

14.

Manne S, Devine K, Hudson S, Kashy D, OMalley D, Paddock L . Factors associated with health-related quality of life in a cohort of cancer survivors in New Jersey. BMC Cancer. 2023; 23(1):664. PMC: 10349446. DOI: 10.1186/s12885-023-11098-5. View

15.

Jiang C, Deng L, Karr M, Wen Y, Wang Q, Perimbeti S . Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002-2018. Cancer. 2021; 128(4):828-838. PMC: 8792209. DOI: 10.1002/cncr.33981. View

16.

Lustberg M, Kuderer N, Desai A, Bergerot C, Lyman G . Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship. Nat Rev Clin Oncol. 2023; 20(8):527-542. PMC: 10211308. DOI: 10.1038/s41571-023-00776-9. View

17.

Prieto-Callejero B, Rivera F, Fagundo-Rivera J, Romero A, Romero-Martin M, Gomez-Salgado J . Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer. Medicine (Baltimore). 2020; 99(33):e21695. PMC: 7437745. DOI: 10.1097/MD.0000000000021695. View

18.

Hung H, Liu C, Chen H, Chang C, Chen S . Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy. Int J Environ Res Public Health. 2021; 18(11). PMC: 8199281. DOI: 10.3390/ijerph18115677. View

19.

Ryan A, Prado C, Sullivan E, Power D, Daly L . Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition. 2019; 67-68:110539. DOI: 10.1016/j.nut.2019.06.020. View

20.

Post C, de Boer S, Powell M, Mileshkin L, Katsaros D, Bessette P . Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial. Int J Radiat Oncol Biol Phys. 2020; 109(4):975-986. DOI: 10.1016/j.ijrobp.2020.10.030. View